SB 239063 (SB239063)是ATP竞争性的、可逆的p38 MAPK选择性抑制剂，作用于p38α的IC₅₀值为 44 nM，但对p38γ/δ无抑制作用，具有神经保护作用，还能减少肺纤维化。

参考文献

[1] Underwood DC, et al. SB 239063, a potent p38 MAP kinase inhibitor, reduces inflammatory cytokine production, airways eosinophil infiltration, and persistence. J Pharmacol Exp Ther. 2000 Apr;293(1):281-8.

[2] Strassburger M, et al. Anti-inflammatory treatment with the p38 mitogen-activated protein kinase inhibitor SB239063 is neuroprotective, decreases the number of activated microglia and facilitates neurogenesis in oxygen-glucose-deprived hippocampal slice cultures. Eur J Pharmacol. 2008 Sep 11;592(1-3):55-61.

[3] Joko T, et al. Involvement of P38MAPK in human corneal endothelial cell migration induced by TGF-β(2). Exp Eye Res. 2013 Mar;108:23-32.

冰袋运输。粉末直接保存于-20℃，有效期3年。建议分装后-20℃干燥保存，避免反复冻融。